The additional diagnostic value of NLR and PLR for CA-125 in the differential diagnosis of endometrioma and benign ovarian cysts in women of reproductive age: a retrospective case-control study
In addition,CA-125 was not associated with clinical symptoms, although a relationship was identified between NLR anddysmenorrhea, and between PLR and lesion size, which may be the research focus of further studies.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objectives: Aim of this study is to investigate the diagnostic value of neutrophil/lymphocyte ratio (NLR) andplatelet/lymphocyte ratio (PLR) for cancer antigen-125 (CA-125) in a differential diagnosis of endometriomafrom benign ovarian cysts.Methods: In this retrospective study, the medical data of a total of 213 patients aged < 40 years who underwentlaparoscopic or laparotomic surgery for ovarian cysts between April 2015 and June 2018 were analyzed.
📊
Key Findings & Data:Data on age, body mass index (BMI), preoperative USfindings, complete blood count analysis results, follicle-stimulating hormone (FSH) levels, and the presenceof dysmenorrhea, dyspareunia and chronic pelvic pain were recorded.Results: NLR, PLR and CA-125 were increased in the patients with endometrioma, although increases in theNLR and PLR alone or combined did not contribute to the sensitivity or specificity of CA-125.Conclusions: The results of our study suggest that NLR and PLR did not contribute to the diagnostic value ofCA-125 in the preoperative differential diagnosis of endometriomas or other benign ovarian cysts.
💡
Conclusion & Impact:In addition,CA-125 was not associated with clinical symptoms, although a relationship was identified between NLR anddysmenorrhea, and between PLR and lesion size, which may be the research focus of further studies.
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters
Abstract
Objectives: Aim of this study is to investigate the diagnostic value of neutrophil/lymphocyte ratio (NLR) andplatelet/lymphocyte ratio (PLR) for cancer antigen-125 (CA-125) in a differential diagnosis of endometriomafrom benign ovarian cysts.Methods: In this retrospective study, the medical data of a total of 213 patients aged < 40 years who underwentlaparoscopic or laparotomic surgery for ovarian cysts between April 2015 and June 2018 were analyzed. Thepatients were divided into two groups, as those with endometriomas and those with other benign ovarian cysts,all which had been confirmed histopathologically. Data on age, body mass index (BMI), preoperative USfindings, complete blood count analysis results, follicle-stimulating hormone (FSH) levels, and the presenceof dysmenorrhea, dyspareunia and chronic pelvic pain were recorded.Results: NLR, PLR and CA-125 were increased in the patients with endometrioma, although increases in theNLR and PLR alone or combined did not contribute to the sensitivity or specificity of CA-125.Conclusions: The results of our study suggest that NLR and PLR did not contribute to the diagnostic value ofCA-125 in the preoperative differential diagnosis of endometriomas or other benign ovarian cysts. In addition,CA-125 was not associated with clinical symptoms, although a relationship was identified between NLR anddysmenorrhea, and between PLR and lesion size, which may be the research focus of further studies.
🔖
Cite This Article
Kalem, M. N., Kalem, Z., Şimşir, Ç., Bakırarar, B. (2022). The additional diagnostic value of NLR and PLR for CA-125 in the differential diagnosis of endometrioma and benign ovarian cysts in women of reproductive age: a retrospective case-control study. The European Research Journal, Cilt: 6 - Sayı: 2, 111–119. https://ajindex.com/articles/591964
Strauss JF, Barbieri RL. Yen & Jaffe's Reproductive Endocrinology E-Book: Physiology, Pathophysiology, and Clinical Management. Elsevier Health Sciences. 2013
Raffi F, Metwally M, Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab 2012;97:3146-54
Tanbo T, Fedorcsak P. Endometriosis-associated infertility: aspects of pathophysiological mechanisms and treatment options. Acta Obstet Gynecol Scand 2017;96:659-67
Clement PB. The pathology of endometriosis: a survey of the many faces of a common disease emphasizing diagnostic pitfalls and unusual and newly appreciated aspects. Adv Anat Pathol 2007;14:241-60
Tsoumpou I, Kyrgiou M, Gelbaya TA, Nardo LG. The effect of surgical treatment for endometrioma on in vitro fertilization outcomes: a systematic review and meta-analysis. Fertil Steril 2009;92:75-87
Somigliana E, Berlanda N, Benaglia L, Viganò P, Vercellini P, Fedele L. Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimüllerian hormone level modifications. Fertil Steril 2012;98:1531-8
Guerriero S, Mais V, Ajossa S, Paoletti AM, Angiolucci M, Melis GB. Transvaginal ultrasonography combined with CA-125 plasma levels in the diagnosis of endometrioma. Fertil Steril 1996;65:293-8
May KE, Conduit-Hulbert SA, Villar J, Kirtley S, Kennedy SH, Becker CM. Peripheral biomarkers of endometriosis: a systematic review. Hum Reprod Update 2010;16:651-74
Fassbender A, Dorien O, De Moor B, Waelkens E, Meuleman C, Tomassetti C, et al. Biomarkers of endometriosis. In: Endometriosis. Springer, Tokyo. 2014:pp. 321-39
Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69:89-95
Knific T, Vouk K, Vogler A, Osredkar J, Gstöttner M, Wenzl R, et al. Models including serum CA-125, BMI, cyst pathology, dysmenorrhea or dyspareunia for diagnosis of endometriosis. Biomark Med 2018;12:737-47
Hirsch M, Duffy JM, Deguara CS, Davis CJ, Khan KS. Diagnostic accuracy of Cancer Antigen 125 (CA125) for endometriosis in symptomatic women: a multi-center study. Eur J Obstet Gynecol Reprod Biol 2017;210:102-7
Templeton AJ, McNamara MG, Šeruga B, Vera-Badillo FE, Aneja P, Ocaña A, et al. Prognostic role of neutrophil-tolymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 2014;106:d